Navigation Links
Cutanea Announces Promising Phase II Results in Rosacea with Omiganan
Date:10/17/2007

tular Rosacea, while oral medications are prescribed for severe disease. Current oral antibiotic therapies may alleviate symptoms of rosacea, but may present an issue with undesirable side effects). While there are other topical products currently available on the market, there is an opportunity to improve the existing irritation profile for these treatments.

About Omiganan

Cutanea Life Sciences licensed the exclusive worldwide rights for dermatological uses to a novel, cationic, antimicrobial peptide, whose active component is omiganan pentahydrochloride from Migenix Inc., a British Columbia Corporation located in Vancouver, BC, Canada (TSX: MGI; OTC: MGIFF). Omiganan is in development as a topical treatment for papulopustular rosacea and may prevent the inflammatory cascade that is theorized to lead to the signs and symptoms of rosacea. Omiganan topical gel has been evaluated in early stage clinical trials at concentrations of 0.5% and 3.0%, and early and late stage trials at 1.0%. At each of these concentrations and in all trials conducted, omiganan was found to be safe, well tolerated and non-irritating with no evidence of systemic absorption. While cationic antimicrobial peptides, such as Omiganan, are well known for their antimicrobial properties, recent research has shown that they also may play a role in the inflammatory response. Omiganan, in in vitro assays, demonstrated a rapid bactericidal activity against microorganisms that colonize the skin and that may play a role in the pathogenesis of inflammatory lesions.

About Cutanea

Cutanea Life Sciences is an emerging specialty pharmaceutical company focused on improving human health and appearance through the development and commercialization of treatments for diseased and aging skin conditions. The Company strives to maximize value through flawless execution of strategically designed programs. Its core strategy is to in-license novel, patented, mid- stage treatment candidates for aggr
'/>"/>

SOURCE Cutanea Life Sciences
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014  Savant HWP, Inc., a privately held ... human safety testing of 18-MC, an experimental treatment ... of 18-MC, administered as part of a double-blind, ... American partner, was well tolerated by healthy volunteers ... develop 18-MC as a treatment for many forms ...
(Date:9/23/2014)... , Sept. 23, 2014   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade hypothermic ... precision thermal shipping products for cells and ... additions to its Scientific Advisory Board.  The new members ... Davies , PhD. Dr. Acker is a ...
(Date:9/22/2014)... September 23, 2014 , ... authorities, increasing rigor for trial master file (TMF) accessibility ... largest TMF survey to date reveals an increase in ... provide auditors with remote access to their electronic trial ... surveyed in the Veeva 2014 Paperless TMF ...
Breaking Medicine Technology:Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 2Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 2Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 3Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 4
... Va., Oct. 8 Mirixa Corporation, the leader ... hiring of Cheryl Hoffer as Vice President, Pharmacy ... Pharmacy Account Management team, supporting independent and chain ... The Pharmacy Account Management team also helps expand ...
... LAKE FOREST, Ill., Oct. 8 Hospira, Inc. (NYSE: ... pharmaceuticals, today signed a Business Cooperation Agreement with South ... outlines the business terms of a future distribution agreement ... Canada for eight biogeneric products that are currently under ...
Cached Medicine Technology:Mirixa Corporation Announces Key Pharmacy Network Hire 2Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs 2Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs 3
(Date:9/23/2014)... UT (PRWEB) September 23, 2014 Pricing ... addition of the following facilities. , 1. Prairie ... & Pain Institute is a nationally recognized leader in ... frequently presents both nationally and internationally on leading-edge, minimally ... experience using these techniques and quicker recovery times for ...
(Date:9/23/2014)... NC (PRWEB) September 23, 2014 Scarless ... open an 18,000 – square foot dermatology and vein ... a nationwide chain of dermatology centers. The center will ... training of healthcare professionals for the treatment of skin ... be led by Kamran Goudarzi, MD, a pioneer in ...
(Date:9/23/2014)... September 23, 2014 Recently, Best Cheap ... Bluehost and JustHost are the best VPS hosting suppliers ... make money from hosting, reseller hosting is a very ... allotted resources to host the others’ websites under his ... is very famous for two primary hosting plans (reseller ...
(Date:9/23/2014)... September 23, 2014 On September 9th, 2014, ... the most technically advanced horticultural LED grow light that they ... the XL750 and XL1000 , releasing a ... the experienced horticulturalist, because it has what the whole community ... Kind LED's grower-tested 12 band spectrum (also known as "the ...
(Date:9/23/2014)... September is Self-Improvement Month and the ... people improve their lives every day. This month long ... small to make improvements in their lives. The idea ... lives and make easy adjustments towards their goals. Whether ... or getting on track with finances, this month is ...
Breaking Medicine News(10 mins):Health News:PricingHealthcare.com Adds Pricing Data for Pittsburgh, New Orleans, Peoria Facilities 2Health News:Scarless VeinCare Partners with DemOne to Open State-of-the-Art Facility for Vein and Dermatology Care 2Health News:Scarless VeinCare Partners with DemOne to Open State-of-the-Art Facility for Vein and Dermatology Care 3Health News:Best Cheap Hosting USA: Bluehost And JustHost Are Ranked As The Best VPS Hosting Suppliers 2Health News:Kind LED K5 Series XL1000 Grow Lights Sell Out in Only 2 Days 2Health News:Emassagechair.com is Celebrating Self-Improvement Month by Giving Away a Foot Massager 2Health News:Emassagechair.com is Celebrating Self-Improvement Month by Giving Away a Foot Massager 3
... Cell phones used by patients and their visitors were twice ... healthcare workers (HCW), according to a study published in the ... , the official publication of APIC - the Association for ... of researchers from the Department of Medical Microbiology at Inonu ...
... 70 different types of dementia, but these findings are shocking. ... the study", say researchers Elisabet Englund and Hans Brunnstrm at ... majority from the cities of Lund and Malm. All of ... the period 1996-2006 and been diagnosed with some form of ...
... Venous thromboembolism (VTE) is the third most common type ... Researchers at the Centre for Primary Health Care Research ... for venous thromboembolism in the entire Swedish population by ... with VTE compared with the children of parents who ...
... Ill. Functional magnetic resonance imaging (fMRI) may provide ... researchers at Columbia University in New York City, who ... children. Results of their study appear online and in ... is a spectrum disorder characterized by repetitive behaviors and ...
... -- Attacks by North American black bears on humans are ... population of the United States and Canada increases, new research ... of Wildlife Management , also dispels the myth that the ... protect. Researchers reveal that lone male black bears hunting people ...
... with asthma get the flu, they often land in the ... found a previously unknown biological pathway explaining why influenza induces ... 29 by the journal Nature Immunology , reveal that ... natural helper cells presenting a completely new set of ...
Cached Medicine News:Health News:Study finds dangerous bacteria on cell phones of hospital patients 2Health News:Difficulties in diagnosing dementia type 2Health News:New research may lead to improved diagnosis of autism 2Health News:Fatal Black Bear Attacks Rare But Rising 2Health News:Why does flu trigger asthma? 2
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
... Sheet. Medpor Sheets are commonly used ... craniofacial applications. The thinner 0.4 mm ... surgeon with greater flexibility and to ... insertion into the orbit. It is ...
... precise punching of the donor corneal ... use with disposable trephine blades. Unique ... centration of the donor tissue. Recessed ... held centrally under the trephine blade. ...
... violet ink stands up ... scale ruler printed on ... quick measuring. Flexible, smudge-proof ... inch and metric scales. ...
Medicine Products: